{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F68f6eedd-4e78-4a1a-b80e-aa6dcc1ea27e","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/68f6eedd-4e78-4a1a-b80e-aa6dcc1ea27e\"></iframe>","title":"Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers","description":"Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/8c104f4d-e244-446d-b79b-09735385f84f/j6sp7yRb3vZGZpaZTaxWb1wr.png"}